Adverum Biotechnologies Inc. buy Chardan Capital
Start price
19.03.24
/
50%
€1.51
Target price
19.03.25
€3.68
Performance (%)
-8.61%
Price
20.03.24
€1.38
Summary
This prediction is currently active. With a performance of -8.61%, the BUY prediction for Adverum Biotechnologies Inc. by Chardan_Capital is down slightly. This prediction currently runs until 19.03.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Adverum Biotechnologies Inc. | - | - |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by Chardan_Capital for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat